Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 19096004)

Published in Am J Respir Crit Care Med on December 18, 2008

Authors

Edoardo Savarino1, Marco Bazzica, Patrizia Zentilin, Daniel Pohl, Andrea Parodi, Giuseppe Cittadini, Simone Negrini, Francesco Indiveri, Radu Tutuian, Vincenzo Savarino, Massimo Ghio

Author Affiliations

1: Division of Gastroenterology, University of Genoa, Genoa, Italy. edoardo.savarino@unige.it

Associated clinical trials:

RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol (RESULT) | NCT01406210

Articles citing this

Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.32

Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther (2010) 1.50

Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med (2010) 1.30

Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest (2013) 1.24

NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11

Interstitial Lung Disease in Idiopathic Inflammatory Myopathy. Curr Rheumatol Rev (2010) 1.07

Scleroderma lung disease. Eur Respir Rev (2013) 1.04

New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs (2011) 1.03

Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther (2014) 0.99

Pulmonary arterial hypertension associated with systemic sclerosis. Expert Rev Respir Med (2011) 0.95

Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90

Interstitial lung disease in scleroderma. Rheum Dis Clin North Am (2015) 0.88

Increased inspiratory esophagogastric junction pressure in systemic sclerosis: an add-on to antireflux barrier. World J Gastroenterol (2015) 0.88

Systemic sclerosis and bilateral lung transplantation: a single centre experience. Eur Respir J (2010) 0.86

Management of Systemic-Sclerosis-Associated Interstitial Lung Disease. Rheum Dis Clin North Am (2015) 0.85

Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol (2015) 0.84

EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84

Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review. Pulm Med (2010) 0.83

Environmental - lifestyle related factors. Best Pract Res Clin Gastroenterol (2010) 0.83

Pictorial review of intrathoracic manifestations of progressive systemic sclerosis. Ann Thorac Med (2014) 0.83

Diagnosis and management of interstitial lung disease. Transl Respir Med (2014) 0.83

Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome. Chest (2010) 0.79

GERD: are functional heartburn and functional dyspepsia one disorder? Nat Rev Gastroenterol Hepatol (2010) 0.79

The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis. BMC Gastroenterol (2015) 0.78

Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep (2015) 0.77

Pulmonary Disease Secondary to Reflux Mimicking Interstitial Pneumonia in Systemic Sclerosis: Case Report and Literature Review. Case Rep Rheumatol (2016) 0.75

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil (2016) 0.75

Lung Transplantation for Scleroderma-related Lung Disease. Curr Respir Care Rep (2014) 0.75

Gastroesophageal reflux and lung disease in systemic sclerosis. Am J Respir Crit Care Med (2009) 0.75

Eosinophilic Esophagitis in Two Patients with Systemic Sclerosis. Case Rep Rheumatol (2016) 0.75

Gastroesophageal reflux disease in our asthma patients: the presence of dysphagia can influence pulmonary function. Multidiscip Respir Med (2012) 0.75

Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study. Cough (2014) 0.75

Esophageal testing: What we have so far. World J Gastrointest Pathophysiol (2016) 0.75

Respiratory dysfunction is common in patients with achalasia and improves after pneumatic dilation. Dig Dis Sci (2013) 0.75

Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis. Rheumatol Int (2017) 0.75

Articles by these authors

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med (2015) 6.71

Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42

Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol (2004) 3.04

Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol (2006) 2.64

The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol (2005) 2.34

Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol (2008) 2.32

Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol (2007) 2.26

An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03

Achalasia: an overview of diagnosis and treatment. J Gastrointestin Liver Dis (2007) 1.76

Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice. Hypertension (2011) 1.73

Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol (2011) 1.69

Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol (2013) 1.65

Clinical relevance of the nutcracker esophagus: suggested revision of criteria for diagnosis. J Clin Gastroenterol (2006) 1.62

Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol (2008) 1.59

Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy. Liver Int (2012) 1.53

Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol (2003) 1.49

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability. Thromb Haemost (2011) 1.48

Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol (2012) 1.47

Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. J Clin Gastroenterol (2006) 1.43

Efficacy of the Za self-expandable metal stent for palliation of malignant biliary obstruction. J Clin Gastroenterol (2004) 1.39

A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs. Intern Emerg Med (2006) 1.39

Migraine during systemic lupus erythematosus: findings from brain single photon emission computed tomography. J Rheumatol (2006) 1.39

The role of proximal pH monitoring. Am J Gastroenterol (2005) 1.38

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis (2011) 1.37

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol (2003) 1.36

CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol (2007) 1.35

Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol (2005) 1.33

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol (2004) 1.32

Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol (2009) 1.32

Technology review: Esophageal impedance monitoring. Am J Gastroenterol (2006) 1.31

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol (2011) 1.29

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28

Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement. Gastrointest Endosc (2005) 1.27

Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens (2011) 1.26

Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. J Immunol (2005) 1.26

Influence of bolus consistency and position on esophageal high-resolution manometry findings. Dig Dis Sci (2007) 1.26

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens (2008) 1.23

NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20

Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol (2003) 1.15

Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J (2013) 1.12

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11

Non-erosive reflux disease is more complex than negative endoscopy only. Am J Gastroenterol (2013) 1.09

Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood (2002) 1.08

Evaluation of cardiac involvement in caucasian patients with skin sarcoidosis. J Cardiovasc Electrophysiol (2015) 1.08

Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease". Dig Liver Dis (2013) 1.07

Which anticoagulant drug should be used to treat portal vein thrombosis in patients with chronic liver disease? Clin Gastroenterol Hepatol (2012) 1.07

Esophageal acid exposure still plays a major role in patients with NERD. J Gastroenterol (2013) 1.06

Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily. Blood (2002) 1.06

Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. Clin Oral Investig (2013) 1.06

Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05

The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol (2014) 1.04

Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. Transfusion (2007) 1.02

External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol (2004) 1.01

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse. Hepatology (2009) 1.00

Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood (2003) 1.00

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. J Med Genet (2012) 1.00

Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens (2010) 0.99

Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol (2008) 0.99

Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol (2009) 0.99

Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology (2012) 0.99

Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB and NF-AT nuclear translocation. J Immunol (2005) 0.98

Characteristics of the esophageal low-pressure zone in healthy volunteers and patients with esophageal symptoms: assessment by high-resolution manometry. Am J Gastroenterol (2008) 0.98

Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol (2009) 0.98

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes. Cancer Immunol Immunother (2013) 0.97

Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci (2006) 0.97